Jun 182020
 

By Talent4Boards Team

Talent4Boards - Great Talent builds Great Boards

– USA, CA – Revolution Medicines, Inc. (Nasdaq: RVMD), a clinical-stage oncology company focused on developing targeted therapies to inhibit frontier cancer targets, today announced the appointments of Dr Eric T. Schmidt, Ph.D., and Peter Svennilson to its board of directors. “Eric and Peter will each strengthen our board's financial ...

Revolution Medicines appoints Dr Eric Schmidt and Peter Svennilson to its Board of Directors

Revolution Medicines appoints Dr Eric Schmidt and Peter Svennilson to its Board of Directors

From:: Revolution Medicines appoints Dr Eric Schmidt and Peter Svennilson to its Board of Directors

Sorry, the comment form is closed at this time.